Extra Renal Origin
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas (NCT03355976) | Brown University | 2018-04-30 |
Track Extra Renal Origin automatically
Every clearance here is in the API, with alerts when new ones post.